A Single Center Pilot Trial of Rituximab in the Treatment of Fibrillary Glomerulonephritis

Trial Profile

A Single Center Pilot Trial of Rituximab in the Treatment of Fibrillary Glomerulonephritis

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Rituximab (Primary)
  • Indications Glomerulonephritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 27 Apr 2016 Planned number of patients changed from 10 to 11.
    • 27 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top